ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1 is a research paper published in Molecular Cell (2022). On theSindex it has a DataRank of 0. It has been cited 23 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Lung Cancer Research Foundation
Grant: R35CA220497
Lung Cancer Research Foundation
Grant: R01 CA233736
Lung Cancer Research Foundation
Grant: U54 OD020355-01
Lung Cancer Research Foundation
Grant: R01 CA204749
Lung Cancer Research Foundation
Grant: R01 CA207244
Lung Cancer Research Foundation
Grant: U01 CA199215
Lung Cancer Research Foundation
Grant: R01 CA201247
Lung Cancer Research Foundation
Grant: P30 CA008748
Japan Agency for Medical Research and Development
Grant: 19cm0106513h0004
Japan Society for the Promotion of Science
Grant: 15KK0303
National Institutes of Health
Grant: P01 CA094060
National Institutes of Health
Grant: R35 CA210085
National Institutes of Health
Grant: 1R01CA201247-01A1
Origins of BRAF-mutant hematologic malignancies and their therapeutic resistance
National Institutes of Health
Grant: 5R35CA210085-06
Studies on oncoprotein-induced feedback: Basic and therapeutic implications
National Institutes of Health
Grant: 5R01CA204749-03
Understanding Long Tail Driver Mutations in Cancer
National Institutes of Health
Grant: 5U54OD020355-04
MSKCC Pilot Center for Precision Disease Modeling
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5P01CA094060-07
Mechanisms of Metastasis and Evasion of TGF-Beta Tumor Suppression Breast Cancer
National Institutes of Health
Grant: 5U01CA199215-02
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
National Institutes of Health
Grant: 5R01CA207244-05
Targeting AKT-Mutant Human Cancers
National Institutes of Health
Grant: 5R35CA220497-03
Development of Combination Therapies to Delay/Prevent Acquired Drug Resistance
National Institutes of Health
Grant: 1R01CA233736-01
Exploiting the distinct genomics and signaling of colorectal cancers to effectively target ERK
NIH HHS
Grant: U54 OD020355
FWCI
1.57
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals